BioStock: Project manager sees great potential in Lipum’s candidate

Umeå-based Lipum is in late preclinical development phase with the candidate drug SOL-116 with the ambition to treat chronic inflammatory diseases. The development work is led by Dr Maria Wanderoy, who recently took up the role as Project Director at Lipum. BioStock contacted Wanderoy to hear her thoughts on the SOL-116 project, her first months working at the company and the development plans for the candidate.

Read the full article at biostock.se:

https://www.biostock.se/en/2022/02/project-manager-sees-great-potential-in-lipums-candidate/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se